Concurrent infections and HIV pathogenesis

[41] Human immunodeficiency viruses in the developing world [J]. ADVANCES IN VIRUS RESEARCH, VOL 53, 1999, 53 : 71 - 88

[42] Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (05) : 597 - 603

[43] ACUTE FATAL TRYPANOSOMA-CRUZI MENINGOENCEPHALITIS IN A HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE HEMOPHILIAC PATIENT [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 45 (06) : 723 - 727

[44] INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) : 2399 - 2403

[45] Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (10) : 869 - 874

[46] African HIV-1 subtype C and rate of progression among ethiopian immigrants in Israel [J]. LANCET, 1997, 349 (9046) : 180 - 181

[47] Garrait V, 1997, J IMMUNOL, V159, P2824

[48] Gea-Banacloche JC, 1999, IMMUNOLOGIST, V7, P124

[49] The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) : 1332 - 1338

[50] Goletti D, 1996, J IMMUNOL, V157, P1271

[41] Human immunodeficiency viruses in the developing world [J]. ADVANCES IN VIRUS RESEARCH, VOL 53, 1999, 53 : 71 - 88

[42] Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (05) : 597 - 603

[43] ACUTE FATAL TRYPANOSOMA-CRUZI MENINGOENCEPHALITIS IN A HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE HEMOPHILIAC PATIENT [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 45 (06) : 723 - 727

[44] INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) : 2399 - 2403

[45] Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (10) : 869 - 874

[46] African HIV-1 subtype C and rate of progression among ethiopian immigrants in Israel [J]. LANCET, 1997, 349 (9046) : 180 - 181

[47] Garrait V, 1997, J IMMUNOL, V159, P2824

[48] Gea-Banacloche JC, 1999, IMMUNOLOGIST, V7, P124

[49] The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) : 1332 - 1338

[50] Goletti D, 1996, J IMMUNOL, V157, P1271